(Q41439948)

30 September 2017

1 reference

title

Gastrointestinal endocrine tumours. Gastrinoma (English)

1 reference

30 September 2017

Jensen RT

1

1 reference

30 September 2017

publication date

1 December 1996

1 reference

Bailliere's clinical gastroenterology

30 September 2017

published in

1 reference

30 September 2017

volume

10

1 reference

30 September 2017

issue

4

1 reference

30 September 2017

page(s)

603-643

1 reference

Somatostatin analogue phase I trials in neuroendocrine neoplasms.

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Results of liver transplantation for gastroenteropancreatic tumor metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Molecular mechanisms of parathyroid neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Somatostatin analog sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Management of gastroenteropancreatic endocrine tumors: the place of somatostatin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Molecular mechanisms of neoplasia in multiple endocrine neoplasia type 1-related and sporadic tumors of the pancreatic islet cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Progastrin in pancreas and the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Molecular pharmacology of somatostatin-receptor subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Apudomas metastatic to the liver: treatment by hepatic artery embolization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Multiple hormone elevations in Zollinger-Ellison syndrome. Prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Comparison of Ranitidine and Cimetidine in the Treatment of Gastric Hypersecretion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Somatostatin receptor localization of pancreatic endocrine tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

The achlorhydria-carcinoid sequence: role of gastrin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Quantitative electron microscopy of endocrine cells in oxyntic mucosa of normal human stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Progastrin and its glycine-extended posttranslational processing intermediates in human gastrointestinal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Resection of Gastrinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Metastatic endocrine tumors: is there a place for liver transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Treatment of malignant endocrine pancreatic tumours with human leucocyte interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Gastrinomas demonstrate amplification of the HER-2/neu proto-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Gastrinomas: comparison of MR imaging with CT, angiography, and US

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Detection of duodenal gastrinomas by operative endoscopic transillumination. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Use of omeprazole in patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Metastatic gastrinomas: localization with selective arterial injection of secretin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Extraction of a gastrin-like substance from a pancreatic tumour in a case of Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Nature of the gastric secretagogue in Zollinger-Ellison tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Aminoacid constitution of two gastrins isolated from Zollinger-Ellison tumour tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Pancreatic polypeptide immunoreactivity in sporadic gastrinoma: relationship to intraabdominal location

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Use of selective arterial secretin injection test to guide surgery in patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Normal serum gastrin concentration in gastrinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Basis for failure of cimetidine in patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Zollinger-Ellison Syndrome: Current Concepts and Management

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Post-translational processing of gastrin in neoplastic human colonic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

1 reference

7 January 2021

Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Gastrin in the human fetus. Distribution and molecular forms of gastrin in the antro-pyloric gland area, duodenum and pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Two G protein oncogenes in human endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Cushing's syndrome in patients with the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

The place of surgery in the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Immunochemical measurement of elevated levels of gastrin in the serum of patients with pancreatic tumors of the Zollinger-Ellison variety.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Flow cytometry and Zollinger-Ellison syndrome: relationship to clinical course.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Helicobacter pylori infection. A reversible cause of hypergastrinemia and hyperchlorhydria which may mimic Zollinger-Ellison syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Current approach to the management of tumoral process in patients with gastrinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Reflux esophagitis in patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Zollinger-Ellison syndrome: technique, results, and complications of portal venous sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

The management of patients with advanced carcinoid tumors and islet cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Aggressive resection of metastatic disease in selected patients with malignant gastrinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Ulcerogenic tumors of the duodenum

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

An evaluation of human recombinant alpha interferon in patients with metastatic gastrinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Hepatic resection for metastatic neuroendocrine carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Orthotopic liver transplantation in the treatment of metastatic neuroendocrine tumors of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Loss of heterozygosity on chromosome 11 in sporadic gastrinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Prospective study of chemotherapy in patients with metastatic gastrinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Multiple endocrine neoplasm, type 1. Gastrinomas, pancreatic neoplasms, microcarcinoids, the Zollinger-Ellison syndrome, lymph nodes, and hepatic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Gastric carcinoids and related endocrine growths

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Histopathological classification of nonantral gastric endocrine growths in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Hepatic arterial chemoembolization for metastatic endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

The role of surgery in the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Absence of mutations in the Gs alpha and Gi2 alpha genes in sporadic parathyroid adenomas and insulinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Peptic ulcer perforation as the presentation of Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Genetic aspects of adenomatosis of endocrine glands

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Zollinger-Ellison syndrome. Current concepts in diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Brief report: a duodenal gastrinoma in a patient with diarrhea and normal serum gastrin concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990016-0

7 January 2021

10.1016/S0950-3528(96)90016-0

Identifiers

DOI

1 reference

30 September 2017

1 reference